The sex ratio in amyotrophic lateral sclerosis: A population based study
- PMID: 20225930
- PMCID: PMC6485484
- DOI: 10.3109/17482961003610853
The sex ratio in amyotrophic lateral sclerosis: A population based study
Abstract
Replicable risk factors for ALS include increasing age, family history and being male. The male: female ratio has been reported as being between 1 and 3. We tested the hypothesis that the sex ratio changes with age in a population register covering the south-east of England. The sex ratio before and after the age of 51 years was compared using a Z-test for proportions. Kendall's tau was used to assess the relationship between age group and sex ratio using incidence and prevalence data. Publicly available data from Italian and Irish population registers were compared with results. There was a significant difference in the proportion of females with ALS between those in the younger group (30.11%) and those in the older group (43.66%) (p = 0.013). The adjusted male: female ratio dropped from 2.5 in the younger group to 1.4 in the older group using prevalence data (Kendall's tau = -0.73, p = 0.039). Similar ratios were found in the Italian but not the Irish registry. We concluded that sex ratios in ALS may change with age. Over-representation of younger patients in clinic registers may explain the variation in sex ratios between studies. Menopause may also play a role.
Conflict of interest statement
Figures


Similar articles
-
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).Neuroepidemiology. 2007;29(1-2):44-8. doi: 10.1159/000108917. Epub 2007 Sep 24. Neuroepidemiology. 2007. PMID: 17898523
-
Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):269-74. doi: 10.3109/21678421.2014.887733. Epub 2014 Feb 26. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24571628
-
Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.Neuroepidemiology. 2009;32(2):81-8. doi: 10.1159/000177032. Epub 2008 Nov 27. Neuroepidemiology. 2009. PMID: 19039239
-
[Clinical course and epidemiological analysis of amyotrophic lateral sclerosis in Szczecin in 1986-1995].Neurol Neurochir Pol. 1999 Jan-Feb;33(1):71-8. Neurol Neurochir Pol. 1999. PMID: 10399726 Review. Polish.
-
The changing picture of amyotrophic lateral sclerosis: lessons from European registers.J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):557-563. doi: 10.1136/jnnp-2016-314495. Epub 2017 Mar 11. J Neurol Neurosurg Psychiatry. 2017. PMID: 28285264 Review.
Cited by
-
Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study.J Neurol. 2019 Jun;266(6):1412-1420. doi: 10.1007/s00415-019-09276-2. Epub 2019 Mar 13. J Neurol. 2019. PMID: 30868220
-
Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective.Cells. 2020 Apr 24;9(4):1065. doi: 10.3390/cells9041065. Cells. 2020. PMID: 32344665 Free PMC article. Review.
-
Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.Acta Neuropathol Commun. 2021 Aug 19;9(1):140. doi: 10.1186/s40478-021-01239-x. Acta Neuropathol Commun. 2021. PMID: 34412701 Free PMC article.
-
Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner.Neurol Neuroimmunol Neuroinflamm. 2021 Feb 2;8(2):e953. doi: 10.1212/NXI.0000000000000953. Print 2021 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33531377 Free PMC article.
-
Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis.Cells. 2024 May 21;13(11):888. doi: 10.3390/cells13110888. Cells. 2024. PMID: 38891021 Free PMC article. Review.
References
-
- Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta. 2006;1762:1150–7. - PubMed
-
- Armon C. An evidence based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–28. - PubMed
-
- Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Sep;1(4):235–50. - PubMed
-
- Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population based study. Neurology. 1999;52:504–9. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous